Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes

Journal of Immunological Methods

Volumn 422, Issue , 2015, Pages 28-34

  Paul, Sinu ^a   Lindestam Arlehamn, Cecilia S ^a   Scriba, Thomas J ^b   Dillon, Myles B C ^a   Oseroff, Carla ^a   Hinz, Denise ^a   McKinney, Denise M ^a   Carrasco Pro, Sebastian ^c   Sidney, John ^a   Peters, Bjoern ^a   Sette, Alessandro ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Epitope prediction; HLA class II restricted T cell epitopes

Indexed keywords

ALLERGEN; BACTERIAL ANTIGEN; EPITOPE; HLA ANTIGEN CLASS 2; HLA DRB1 ANTIGEN; HLA DRB4 ANTIGEN; HLA DRB5 ANTIGEN; PERTUSSIS VACCINE; HLA DRB3 ANTIGEN; PEPTIDE; PROTEIN BINDING;

ALLELE; ARTICLE; BORDETELLA PERTUSSIS; COCKROACH; CONSENSUS; EVALUATION STUDY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PERTUSSIS; PREDICTION; PRIORITY JOURNAL; T LYMPHOCYTE; VALIDATION STUDY; ALGORITHM; EPITOPE MAPPING; IMMUNOLOGY;

BACTERIA (MICROORGANISMS);

ALGORITHMS; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DRB1 CHAINS; HLA-DRB3 CHAINS; HLA-DRB4 CHAINS; HLA-DRB5 CHAINS; HUMANS; PEPTIDES; PROTEIN BINDING;

EID: 84930761492     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2015.03.022     Document Type: Article

References (16)

1. Arlehamn C.S., Sidney J., Henderson R., Greenbaum J.A., James E.A., Moutaftsi M., Coler R., McKinney D.M., Park D., Taplitz R., Kwok W.W., Grey H., Peters B., Sette A. Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ). J. Immunol. 2012, 188:5020.
2. Chaves F.A., Lee A.H., Nayak J.L., Richards K.A., Sant A.J. The utility and limitations of current web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection. J. Immunol. 2012, 188:4235.
3. Greenbaum J., Sidney J., Chung J., Brander C., Peters B., Sette A. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 2011, 63(6):325.
4. Kim Y., Ponomarenko J., Zhu Z., Tamang D., Wang P., Greenbaum J., Lundegaard C., Sette A., Lund O., Bourne P.E. Immune epitope database analysis resource. Nucleic Acids Res. 2012, 40:W525.
5. McKinney D.M., Southwood S., Hinz D., Oseroff C., Arlehamn C.S.L., Schulten V., Taplitz R., Broide D., Hanekom W.A., Scriba T.J. A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population. Immunogenetics 2013, 65(5):1.
6. Nielsen M., Lundegaard C., Lund O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinf. 2007, 8:238.
7. Nielsen M., Lund O., Buus S., Lundegaard C. MHC Class II epitope predictive algorithms. Immunology 2010, 130:319.
8. Oseroff C., Sidney J., Kotturi M.F., Kolla R., Alam R., Broide D.H., Wasserman S.I., Weiskopf D., McKinney D.M., Chung J.L. Molecular determinants of T cell epitope recognition to the common Timothy grass allergen. J. Immunol. 2010, 185:943.
9. Oseroff C., Sidney J., Tripple V., Grey H., Wood R., Broide D.H., Greenbaum J., Kolla R., Peters B., Pomés A. Analysis of T cell responses to the major allergens from German cockroach: epitope specificity and relationship to IgE production. J. Immunol. 2012, 189:679.
10. Paul S., Kolla R.V., Sidney J., Weiskopf D., Fleri W., Kim Y., Peters B., Sette A. Evaluating the immunogenicity of protein drugs by applying in vitro MHC binding data and the immune epitope database and analysis resource. Clin. Dev. Immunol. 2013, 2013.
11. Paul S., Weiskopf D., Angelo M.A., Sidney J., Peters B., Sette A. HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity. J. Immunol. 2013, 191:5831.
12. Robinson J., Waller M.J., Parham P., de Groot N., Bontrop R., Kennedy L.J., Stoehr P., Marsh S.G. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 2003, 31:311.
13. Sidney J., Southwood S., Moore C., Oseroff C., Pinilla C., Grey H.M., Sette A. Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture. Curr. Protoc. Immunol. 2013, 18(3):1-18.3.36.
14. Vita R., Overton J.A., Greenbaum J.A., Ponomarenko J., Clark J.D., Cantrell J.R., Wheeler D.K., Gabbard J.L., Hix D., Sette A., Peters B. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 2015, 43(D1):D405-D412.
15. Wang P., Sidney J., Kim Y., Sette A., Lund O., Nielsen M., Peters B. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinf. 2010, 11(1):568.
16. Zhang Q., Wang P., Kim Y., Haste-Andersen P., Beaver J., Bourne P.E., Bui H.H., Buus S., Frankild S., Greenbaum J., Lund O., Lundegaard C., Nielsen M., Ponomarenko J., Sette A., Zhu Z., Peters B. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res. 2008, 36:W513.